-
Fund Dashboard
- Holdings
Biotechnology Fund
Fund Profile
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 9.72 mm | 49.20 k shares | 8.74 | Common equity | Long | USA |
AMGN Amgen Inc. | 6.68 mm | 20.72 k shares | 6.01 | Common equity | Long | USA |
GILD Gilead Sciences, Inc. | 5.19 mm | 61.91 k shares | 4.67 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 4.45 mm | 9.57 k shares | 4.00 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 4.15 mm | 3.94 k shares | 3.73 | Common equity | Long | USA |
CTVA Corteva, Inc. | 3.32 mm | 56.44 k shares | 2.99 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 3.05 mm | 11.10 k shares | 2.75 | Common equity | Long | USA |
AstraZeneca plc
|
2.97 mm | 38.10 k shares | 2.67 | Common equity | Long | UK |
BIIB Biogen Inc. | 2.71 mm | 14.01 k shares | 2.44 | Common equity | Long | USA |
MRNA Moderna, Inc. | 2.70 mm | 40.35 k shares | 2.43 | Common equity | Long | USA |
ILMN Illumina, Inc. | 2.41 mm | 18.49 k shares | 2.17 | Common equity | Long | USA |
First American Government Obligations Fund - Class X | 2.24 mm | 2.24 mm shares | 2.01 | Short-term investment vehicle | Long | USA |
UTHR United Therapeutics Corporation | 2.07 mm | 5.79 k shares | 1.87 | Common equity | Long | USA |
NTRA Natera, Inc. | 1.98 mm | 15.63 k shares | 1.78 | Common equity | Long | USA |
Royalty Pharma plc
|
1.95 mm | 69.08 k shares | 1.76 | Common equity | Long | USA |
PCVX Vaxcyte, Inc. | 1.87 mm | 16.34 k shares | 1.68 | Common equity | Long | USA |
VTRS Viatris Inc. | 1.85 mm | 159.68 k shares | 1.67 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 1.81 mm | 26.52 k shares | 1.63 | Common equity | Long | USA |
INSM Insmed Incorporated | 1.76 mm | 24.18 k shares | 1.59 | Common equity | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 1.72 mm | 13.75 k shares | 1.55 | Common equity | Long | USA |
INCY Incyte Corporation | 1.71 mm | 25.90 k shares | 1.54 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 1.70 mm | 24.24 k shares | 1.53 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 1.69 mm | 14.65 k shares | 1.52 | Common equity | Long | USA |
LEGN Legend Biotech Corporation | 1.51 mm | 30.90 k shares | 1.35 | Common equity | Long | Cayman Islands |
Alkermes plc
|
1.49 mm | 53.38 k shares | 1.34 | Common equity | Long | USA |
BNTX BioNTech SE | 1.42 mm | 11.99 k shares | 1.28 | Common equity | Long | Germany |
ARGX argenx SE | 1.42 mm | 2.62 k shares | 1.28 | Common equity | Long | Netherlands |
RVMD Revolution Medicines, Inc. | 1.40 mm | 30.79 k shares | 1.26 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 1.37 mm | 52.80 k shares | 1.23 | Common equity | Long | USA |
ITCI Intra-Cellular Therapies, Inc. | 1.35 mm | 18.51 k shares | 1.22 | Common equity | Long | USA |
CRISPR Therapeutics AG
|
1.35 mm | 28.83 k shares | 1.22 | Common equity | Long | USA |
Jazz Pharmaceuticals plc
|
1.35 mm | 12.08 k shares | 1.21 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 1.32 mm | 23.07 k shares | 1.19 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 1.27 mm | 20.10 k shares | 1.14 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 1.23 mm | 23.35 k shares | 1.11 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 1.22 mm | 13.17 k shares | 1.10 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 1.22 mm | 26.46 k shares | 1.09 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 1.18 mm | 102.53 k shares | 1.06 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 1.18 mm | 29.37 k shares | 1.06 | Common equity | Long | USA |
MEDP Medpace Holdings, Inc. | 1.10 mm | 3.29 k shares | 0.99 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 1.09 mm | 19.70 k shares | 0.98 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 1.02 mm | 20.02 k shares | 0.92 | Common equity | Long | USA |
AXSM Axsome Therapeutics, Inc. | 956.85 k | 10.65 k shares | 0.86 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 930.21 k | 36.54 k shares | 0.84 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 925.95 k | 25.78 k shares | 0.83 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 918.90 k | 39.29 k shares | 0.83 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 880.90 k | 82.48 k shares | 0.79 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 834.84 k | 18.48 k shares | 0.75 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 826.36 k | 88.00 k shares | 0.74 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 810.89 k | 21.86 k shares | 0.73 | Common equity | Long | USA |
GH Guardant Health, Inc. | 804.94 k | 35.09 k shares | 0.72 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 799.99 k | 7.82 k shares | 0.72 | Common equity | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 783.27 k | 27.16 k shares | 0.70 | Common equity | Long | USA |
NVAX Novavax, Inc. | 766.10 k | 60.66 k shares | 0.69 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 752.83 k | 38.87 k shares | 0.68 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 733.10 k | 35.67 k shares | 0.66 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 689.49 k | 44.83 k shares | 0.62 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 688.64 k | 21.49 k shares | 0.62 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 681.33 k | 103.39 k shares | 0.61 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 678.25 k | 23.79 k shares | 0.61 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 676.58 k | 98.20 k shares | 0.61 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 629.33 k | 56.49 k shares | 0.57 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 578.25 k | 23.60 k shares | 0.52 | Common equity | Long | USA |
KRYS Krystal Biotech, Inc. | 560.83 k | 3.08 k shares | 0.50 | Common equity | Long | USA |
Madrigal Pharmaceuticals, Inc. | 553.26 k | 2.61 k shares | 0.50 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 511.43 k | 17.83 k shares | 0.46 | Common equity | Long | USA |
J.P. Morgan Securities LLC | 399.39 k | 399.39 k principal | 0.36 | Repurchase agreement | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 367.85 k | 89.29 k shares | 0.33 | Common equity | Long | USA |
BofA Securities, Inc. | 329.88 k | 329.88 k principal | 0.30 | Repurchase agreement | Long | USA |
SAGE Sage Therapeutics, Inc. | 314.98 k | 43.63 k shares | 0.28 | Common equity | Long | USA |